Damora Therapeutics (DMRA) Preferred Shares (2025 - 2026)
Damora Therapeutics (DMRA) reported Preferred Shares of $117.6 million for Q1 2026, little changed quarter-over-quarter from $117.6 million in Q4 2025.
Damora Therapeutics (DMRA) Preferred Shares (2025 - 2026) Analysis & Trends
Damora Therapeutics has reported Preferred Shares for 2 years, with the latest figure at $117.6 million in Q1 2026.
- For the quarter ending Q1 2026, Preferred Shares changed N/A year-over-year to $117.6 million; the trailing twelve-month figure through Mar 2026 stood at $117.6 million (changed N/A YoY), and the FY2025 full-year result was $117.6 million, changed N/A from the prior year.
- Preferred Shares for Q1 2026 stood at $117.6 million, roughly flat from $117.6 million in the prior quarter.
- The five-year high for Preferred Shares was $117.6 million in Q4 2025, with the low at $117.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Damora Therapeutics | 731.26 Mn | 528.86 Mn | - | 117.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 117.62 Mn |
| Dec 31, 2025 | 117.62 Mn |